Introduction
Previous transgenic animal experiments indicate that expression of growth hormone ( GH) transgenes in swine reduces carcass fat content, enhances growth rates, and increases efficiency of feed utilization in some animals (Ebert et al., 1988; Vize et al., 1988; Pursel et al., 1989) . However, use of gene promoters, such as a mouse metallothionein ( mMT) , a human metallothionein ( hMT) , a rat phosphoenolpyruvate carboxykinase ( rPEPCK) , a mouse transferrin ( mTF) , a cytomegalovirus LTR, or a Maloney leukemia virus LTR induced transgene-encoded GH expression throughout the animal's life with adverse consequences on subsequent health and well-being (Pursel et al., 1987; Ebert et al., 1988; Vize et al., 1988; Ebert et al., 1990; Pursel et al., 1990a; Weighart et al., 1990) . In contrast, the health status is normal in swine that do not express their GH transgene (Pursel et al., 1987) , only express the GH transgene in brief episodic bursts (Polge et al., 1989) , or receive daily injections of recombinant GH over the latter portion of the pre-market growth period (for review, see Steele and Evock-Clover, 1993) . Shanahan et al. (1989) discovered that transgenic mice carrying a fusion gene composed of the ovine metallothionein-1a ( oMT1a) promoter and genomic ovine GH ( oGH) sequence expressed only a low level of oGH that could be induced 10-to 30-fold by addition of 25 mM zinc sulfate to the drinking water. One of these lines of transgenic mice has subsequently been used for several experiments on bone growth and lipid metabolism (Oberbauer et al., 1992; Pomp 1992 Pomp , 1996 Chow et al., 1994) . Paradoxically, transfer of this same oMT1a-oGH fusion gene into sheep resulted in three transgenic lambs with plasma oGH concentrations of 3,800 to > 26,000 ng/mL .
The objective of the present study was to determine whether integration of the oMT1a-oGH transgene in swine would result in animals with low levels of oGH expression that could be induced by dietary zinc supplementation.
Materials and Methods

Animals
Forty-nine sexually mature crossbred (Yorkshire, Landrace, Hampshire) gilts that had previously displayed estrus two or more times were used for the experiment. Gilts were penned and fed outdoors in groups of 10 and checked for estrus once daily with a mature boar before assignment to experimental use. The gilts were confined to a gestation stall for individual feeding of altrenogest (Regu-Mate ® , Hoechst Roussel Pharmaceuticals, Somerville, NJ).
Synchronization of Estrus and Ovulation
Estrous cycles of all ovum donors and recipients were regulated by feeding .17 mg altrenogest/kg body weight daily for 5 or 6 d starting on d 11 to 15 of the estrous cycle (onset of estrus = d 0). Donors received 1,500 IU PMSG (Diosynth, Chicago, IL) by subcutaneous injection at 16 h and 500 to 750 IU hCG by intramuscular injection at 95 h after the last feeding of altrenogest. Donor gilts were bred by natural service or artificially inseminated twice between 7 and 33 h after the hCG injection. Eight donor gilts (designated D-R)were also used as recipients of microinjected zygotes that had previously been recovered from other donors. Micromanipulated ova were transferred into these donors immediately after their ova had been flushed from the oviducts.
Control recipient gilts ( C-R) were injected with 500 to 750 IU hCG at 117 h after a last feeding of altrenogest (C-R gilts were last fed altrenogest 16 h before and were injected with hCG 6 h after donor gilts).
Ovum Recovery, Microinjection, and Transfer
Ova were recovered from donors between 51 and 55 h after the hCG injection. Anesthesia was induced by intravenous injection of 1,200 mg of ketamine HCl (Ketaset ® , Aveco Co., Fort Dodge, IA) and 60 mg of acepromazine maleate (PromAce ® , Aveco Co.) 20 to 30 min after preanesthetic tranquilization with 20 mg of acepromazine maleate and 15 mg of atropine sulfate (The Butler Company, Columbus, OH). Oviducts were exteriorized by midventral laparotomy, and each oviduct was retrograde flushed with 20 mL of Beltsville Embryo Culture Medium (without 5% CO 2 ) , which was the only medium used for ovum culture from recovery to transfer (Pursel and Wall, 1996) .
Ova were centrifuged at 15,000 × g for 10 min to permit visualization of the pronuclei (Wall et al., 1985) . One pronucleus of each zygote was microinjected with several hundred copies of the oMT1a-oGH fusion gene. Within 2 h after microinjection, 18 to 30 injected ova and three uninjected ova were transferred into one oviduct of either D-R gilts or C-R gilts. Ova were recovered from four to five donors each day. Ova from early recoveries were transferred into subsequent donors (D-R), and ova from later recoveries were transferred into C-R gilts.
Gene Construct
The fusion gene used for microinjection was composed of the 5′ proximal flanking region of the ovine metallothionein-1a gene joined to the coding and 3′ untranslated sequences of the ovine growth hormone gene, described earlier as the MTsGH9 gene .
Farrowing
Recipients were brought into the farrowing barn on d 108 of pregnancy. Each recipient received 15 mg of Lutalyse ® (The Upjohn Company, Kalamazoo, MI) on 112 d of pregnancy to induce parturition. One day after birth, the tip of each pig's tail was removed for DNA analysis by PCR. Pigs that were found to be positive for the transgene by PCR were subsequently confirmed by Southern blot hybridization. No rearrangements of the oGH transgene were detected.
Blood Collection and Assay
Blood was collected from an ear vein of all pigs at approximately 1 wk of age and from transgenic pigs at weaning and at 2-wk intervals thereafter. During the zinc-induction trial, blood was collected from the anterior vena cava of transgenic and control pigs 1 and 3 d before and on d 2, 4, and 6 during supplementation. Plasma was separated by centrifugation and stored at −20°C until assayed.
Concentrations of oGH were determined by RIA using USDA-bGH-B-1 as standard, USDA-bGH-I-1 for radiolabeled ligand, and 1-1-4-anti-bGH serum, which had previously been validated for assay of pig plasma . Plasma samples (75 mL ) were assayed in duplicate. The intraassay CV was 17.3%. Cross-reactivity of USDA-pGH-B-1 was .25%.
Animals and Diets
At weaning on d 28 each transgenic was paired with a non-transgenic littermate of the same sex, if possible, and housed in a nursery with free choice feed Figure 1 . Plasma concentrations of oGH in six non-transgenic pigs and seven oGH transgenic pigs before and during supplementation of feed with 2,000 ppm of zinc. Sex of pig is indicated after the number (M for male, F for female). and water. Transgenic pig 7203 was the only female in the litter, so no control was assigned. At approximately 20 kg body weight, pigs were moved from the nursery and housed with two to four pigs per pen. Body weights were recorded at weekly intervals. The pigs were given ad libitum access to a pelleted cornsoybean meal diet containing 3.5 Mcal of digestible energy, 18% crude protein, and 1.2% lysine until they reached 90 to 100 kg body weight. At 124 to 131 d of age, one transgenic pig with low oGH expression (7203), six transgenic pigs with no discernible oGH expression, and six non-transgenic littermate control pigs were fed the same diet supplemented with 2,000 ppm of zinc (ZnO) for six consecutive days. The seven transgenic and six control pigs averaged 86.6 kg and 88.9 kg, respectively, at the beginning of the zinc supplementation study. The experimental protocols used in this research were approved by the Beltsville Area Institutional Animal Care and Use Committee.
Carcass and Lean Tissue Composition
Three transgenic pigs expressing > 900 ng oGH/mL of plasma and their littermate controls were killed between 145 and 151 d of age at about 100 kg body weight. The organs were weighed and the left side of each intact carcass was chilled for 24 h, evaluated for carcass traits, and ground. Tissue samples were analyzed for lipid, protein, water, and cholesterol content (Solomon et al., 1994b) . Within 15 min after slaughter, the right longissimus muscle was removed and a 5-cm × 1-cm × 1-cm sample from the region over the 12th rib was restrained on a flat stick with nylon twine and frozen in liquid nitrogen. These tissue samples were sectioned and stained, and fiber type distribution and cross-sectional area of each fiber type was determined as described by Solomon et al. (1994a) . Fibers were classified as bR, aR, or aW according to Ashmore and Doerr (1971) on the basis of stain reaction. Additional samples of the longissimus muscle from this same region were removed 1 h postmortem and immediately frozen for subsequent determination of lipid composition and cholesterol content (Solomon et al., 1994b) or chilled to 2°C for 5 d and frozen for shear-force determination using a Warner-Bratzler shear device (Solomon et al., 1991) .
Statistical Analysis
Data were analyzed using GLM procedures (SAS, 1988) . The model used for analysis of daily gain, organ weights (converted to 100 kg live weight basis), and carcass components consisted of main effects of genotype, sex, and resulting interactions with pig considered the experimental unit. Treatment means were compared by least significant differences.
Results
Production of Transgenic Pigs
Of the 37 potential donors that were used for the experiment, 26 were in estrus at the desired time and produced a total of 669 ova. Of these ova, 614 were centrifuged and used for microinjection and 54 uninjected zygotes were kept for transfer into recipients along with microinjected zygotes (Table 1 ). The 17 recipient gilts received a total of 400 injected zygotes along with 51 uninjected zygotes. Thirteen recipients became pregnant and produced a total of 109 pigs of which approximately 25 would have been from uninjected zygotes. The transgene integrated in 15 pigs (seven males and eight females).
Expression of oGH Transgene
The level of gene expression varied greatly among the transgenic pigs. Five transgenic pigs exhibited high levels of oGH expression with plasma concentrations exceeding 900 ng oGH/mL in all samples without dietary zinc supplementation. One transgenic pig (7203) exhibited a low level of expression before zinc stimulation that varied from 10 to 38 ng oGH/mL. The plasma oGH concentrations of six transgenic pigs were similar to the background concentration of the nontransgenic littermate control pigs. The level of expression for the remaining three transgenic pigs was not determined because they either were stillborn or died before blood samples were collected.
Induction of oGH Expression
The effects of dietary zinc supplementation on plasma oGH concentrations of seven transgenic pigs and six littermate controls are graphically shown in Figure 1 . After 6 d of zinc supplementation the plasma oGH concentration for transgenic pig 7203 was almost 20-fold higher than the pretreatment level. The plasma oGH concentrations of transgenic pigs 6904 and 7102 seemed to be somewhat higher on d 6 of zinc supplementation, but it was unclear whether this was a true elevation due to induction or just a sporadically high oGH assay value, because occasional high oGH values were also observed in one or more of the nontransgenic littermate controls.
A second zinc-induction treatment was initiated for a 9-d period for transgenic pigs 7102, 6904, and 6910 along with their non-transgenic littermate controls. The second zinc induction trial failed to result in stimulation of plasma oGH in any of the transgenic pigs (data not shown).
Growth Performance
The birth and weaning weights of the transgenic pigs did not differ from those of their littermates ( P = .40 for birth weight; P = .59 for weaning weight). The average daily gain of the five transgenic pigs with elevated oGH (1.09 kg for females; 1.08 kg for males) was similar to that of littermate control pigs (.99 kg for females; 1.08 kg for males) during a 9-wk feeding trial ( P = .52 for gene; P = .62 for sex; P = .57 for interaction). Group feeding of the pigs precluded collection of data on appetite and efficiency of feed utilization. Average daily gain of the six transgenic pigs that did not have elevated oGH did not differ from that of their littermate controls. 
Carcass Composition
The organ weights for liver, kidney, adrenal, and thyroid were all significantly heavier for the oGHexpressing transgenic pigs than for littermate controls, and weights of heart and spleen were similar for transgenic and control pigs (Table 2) .
Total carcass fat, longissimus muscle fat, subcutaneous backfat thickness, and loin eye area were significantly lower and carcass protein and water content and bR fiber area of longissimus muscle were significantly higher in the transgenic pigs with elevated oGH than in their littermate controls (Table  3) . However, transgenic and control pigs did not differ in cholesterol content for either the carcass or longissimus muscle, shear-force values, percentage of each fiber type, and areas of aR and aW fibers for longissimus muscle (Table 3) .
Discussion
The high pregnancy rate of 76% was a major contributing factor in obtaining an overall transgenic efficiency of 3.5%. This rate of efficiency is higher than we have previously obtained, but it is within the range reported by others (Ebert et al., 1990) .
The oMT1a promoter provided high levels of oGH expression in five pigs, low-level expression in one pig, and no expression in six pigs. Such variability in expression among transgenic founders is thought to be the result of differences in the site of integration, number of gene copies that integrate, and mosaicism in some founders (Palmiter and Brinster, 1986) . The plasma concentration of oGH in the five transgenic pigs with high levels of expression was somewhat lower than the oGH concentrations found in transgenic sheep that harbored the identical transgene (3,800 to > 26,000 ng oGH/mL; Murray et al., 1989) . In contrast, only pig 7203 expressed oGH at a level comparable to the five lines of oGH transgenic mice (< 30 ng oGH/mL) reported by Shanahan et al. (1989) . Why only half of the transgenic pigs expressed the transgene, even though the incidence of expression was three out of three for sheep and five out of six for mice that had integrated the same transgene, remains an enigma. We previously observed diverging results when a mMT-human growth hormone-releasing factor transgene was transferred into the same three species; two of seven pigs , one of seven sheep (Rexroad et al., 1989) , and 11 of 14 mice expressed the gene (Hammer et al., 1985b) .
The inducibility of the oMT1a promoter in pig 7203 was similar to the 20-to 30-fold induction reported for mice harboring the same transgene (Shanahan et al., 1989; Oberbauer et al., 1992) . In this pig, supplementation of feed with 2,000 ppm zinc resulted in a sevenfold induction in 2 d, a 14-fold induction in 4 d, and almost a 20-fold induction in 6 d. The sevenfold induction after 2 d of zinc supplementation is considerably higher than the 1.5-to twofold induction we previously observed in mMT-bGH transgenic pigs (Pursel et al., 1990a) . In these earlier investigations with mMT-GH transgenic pigs, the concentrations of GH were less than 100 ng/mL in four of six bGH founders and four of seven hGH founders . Therefore, it seems that even though the oMT1a promoter may be more inducible than the mMT promoter in swine, the former tends to provide a higher level of constitutive expression than the mMT promoter. Unfortunately, pig 7203 died suddenly after termination of zinc supplementation. Consequently, we were unable to establish whether her low level of expression was a result of mosaicism, how high the oGH concentration would go before reaching a plateau during long-term zinc supplementation, or how long it would take for oGH to return to baseline levels after supplementation was terminated. A necropsy revealed that death resulted from acute gastric hemorrhage due to ulceration of the pars esophagea. A high incidence of pars esophageal ulceration has previously been reported in bGH transgenic pigs and in some pigs receiving porcine GH (pGH) by injection (Machlin, 1972; Smith et al., 1990 Smith et al., , 1991 Baile et al., 1995) .
The significant enlargement of liver, kidney, adrenal, and thyroid of oGH transgenic pigs (Table 2 ) was in close agreement with previous observations in bGH transgenic pigs . Pronounced selective visceromegaly also occurred in oGH transgenic sheep and mice (Nancarrow et al., 1991; Pomp et al., 1992) and in transgenic mice harboring rat and human GH transgenes (Hammer et al., 1985a; Shea et al., 1987; Brem et al., 1989) . A similar degree of organ enlargement occurs in pigs after exogenous treatment with pGH injections or sustained-release implants (Evock et al., 1988; Klindt et al., 1992 Klindt et al., , 1995 .
The growth rate and carcass composition of the transgenic pigs that expressed oGH were in general agreement with results we obtained earlier with transgenic pigs expressing bovine growth hormone (Pursel et al., , 1990b . Although the oGH transgenic pigs did not gain weight faster than their littermates, they showed a trend similar to that seen in two lines of bGH transgenic pigs that gained 11.1 and 13.7% faster than their sibling littermates. The effects of elevated GH resulted in marked repartitioning of carcass components away from subcutaneous and intramuscular fat and into carcass protein (Table  3) . In comparison to littermate controls, oGH transgenic pigs had 90% less subcutaneous backfat thickness, 64% less intramuscular fat in the loin, and 82% less total carcass lipid. This reduction in fat content in the transgenic pigs resulted in a concomitant 28% increase in carcass protein and a 27% increase in water content, which is in close agreement with the 30% increase in water content observed in bGH transgenic pigs compared to sibling controls (Pursel and Solomon, 1993) .
The decline in fat deposition was not matched with increases in loin eye area, as occurs in swine after treatment with exogenous pGH (Evock et al., 1988; Solomon et al., 1994a) . In fact, the loin eye areas of the oGH transgenic pigs were 7% smaller than those of the control pigs. These results are similar to those with bGH transgenic pigs that had loins that weighed 13% less than their sibling controls (Pursel and Solomon, 1993) . Why expression of GH in transgenic pigs did not stimulate muscle hypertrophy as is seen in pigs treated with exogenous GH remains an enigma. We have previously hypothesized that lack of GH pulsatility in transgenic animals may be at the root of the phenomenon because it is well established that continuous infusion of GH is less effective than pulsatile injections for stimulation of growth in rats (Clark et al., 1985) . Buonomo et al. (1991) have shown that daily injections of pGH were more effective than sustained-release implants for enhancing the weight of trimmed loin and loin eye areas of barrows. In addition, Klindt et al. (1995) found no significant enhancement of loin eye areas or weights of trimmed primal cuts in intact boars after up to 18 wk of treatment with sustained-release pGH implants in comparison to control boars.
In comparison to littermate controls, the percentages and areas of each fiber type in the longissimus muscle of oGH transgenic pigs (Table 3 ) showed the same trends that we observed in mMT-bGH transgenic pigs, except that the aW fibers were significantly smaller in the bGH transgenic pigs (Pursel and Solomon, 1993) . In the majority of studies of longissimus muscle morphology in pigs treated with exogenous pGH, all fiber types were enlarged, which is consistent with the observed muscle hypertrophy (Solomon et al., 1991 (Solomon et al., , 1994a Lefaucheur et al., 1992) .
In conclusion, this study indicates that even though an oMT1a-oGH fusion gene was able to markedly alter carcass composition of transgenic swine, the oMT1a promoter did not provide the rigorous regulation of transgene expression that is necessary to provide animals with elevated GH for a limited duration.
Implications
The present experiment demonstrated that expression of an ovine growth hormone transgene could be orally induced, but the base level of expression was too high for this transgene to provide the high degree of regulation that will be necessary for practical use in swine. High-level expression of the transgene resulted in a dramatic reduction in carcass fat with a concomitant increase in carcass protein and moisture content. The development of a controllable transgene expression system that functions in farm animals is still greatly needed.
